Elagolix- A Novel Drug For Endometriosis
Journal Title: JOURNAL OF MEDICAL COLLEGE CHANDIGARH - Year 2017, Vol 7, Issue 2
Abstract
Endometriosis is a chronic inflammatory condition effecting women in their reproductive years. The common symptoms of endometriosis include dysmenorrhea, nonmenstrual pelvic pain, and dyspareunia. It is one of the important factors associated with infertility. Many drugs and hormonal preparations are used for management of endometriosis related pain. Certain surgical interventions may be done if patients do not respond to oral therapy. Elagolix is an oral, nonpeptide, gonadotropin-releasing hormone (GnRH) antagonist that suppresses ovarian estrogen production in dose dependent manner. The content of this article reviews the details of this oral drug.
Authors and Affiliations
Jagjit Singh, Rajiv Kumar
Keywords
Related Articles
- EP ID EP312470
- DOI -
- Views 108
- Downloads 0
PCSK9 Inhibitors: Changing face of dyslipidemia management
Dyslipidemia is one of the major risk factors associated with cardiovascular disease and mortality thereof. A novel drug group, PCSK9 inhibitors has been proven to be highly effective in managing difficult dyslipidemias...
Intracapsular dissection in cervical sympathetic chain schwannoma: a case report
Cervical sympathetic chain schwannoma often presents as an asymptomatic single neck mass, which generally grows slowly and rarely undergoes malignant change. Definitive pre-operative diagnosis at times may become difficu...
Snapping Elbow due to Isolated Ulnar Nerve Dislocation- A Rare Case Report
Ulnar nerve instability without compression at the cubital tunnel is not common and even rarer is a dislocating nerve. Snapping around the medial humeral epicondyle can also be caused by a subluxing medial head of the tr...
Infected Epidermoid Cyst Mimicking As Thyroglossal Fistula: A Case Report
Congenital anomalies in the neck region are formed at birth, however, the resulting lump or complications related to them appear sometimes in later adult life. Thyroglossal cysts and fistula are the commonest congenital...
Lesinurad: A novel drug for the treatment of hyperuricemia associated with Gout in combination with a Xanthine Oxidase Inhibitor
Lesinurad is a selective inhibitor of URAT 1(Uric acid absorption inhibitor) and doesn’t inhibit organic anion transporters (e.g. OAT1 & 3) which make it to be an effective uricosuric agent with minimal clinically signi...